Schedule 13G ownership disclosure

Trevi Therapeutics Inc

Security class unavailable · CUSIP: 89532M101

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,324,319
Percent of class
35.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-20-001546
Form type
SC 13G
Filer
TPG Group Holdings (SBS) Advisors, Inc.
CIK
CIK 1495741
Filed
Feb 13, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub